Annual General Meeting 2019
The Annual General Meeting for 2019 will be on Thursday, April 4, 2019. Read more
Applying our peptide platform to specialty disease areas to invent novel therapies.
Advancing fully owned development programs with Phase 3 in two rare disease programs. See our pipeline